$JKSM
Jacksam Corp

2023 Q3 Form 10-Q Financial Statement

#000147793223007182 Filed on September 28, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $190.7K $402.6K
YoY Change -61.3% -72.56%
Cost Of Revenue $92.61K $247.6K
YoY Change -78.54% -76.25%
Gross Profit $98.14K $155.0K
YoY Change 59.74% -63.52%
Gross Profit Margin 51.45% 38.5%
Selling, General & Admin $88.78K $91.08K
YoY Change -49.22% -59.68%
% of Gross Profit 90.47% 58.75%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $290.00 $0.00
YoY Change 107.14% -100.0%
% of Gross Profit 0.3% 0.0%
Operating Expenses $111.8K $142.4K
YoY Change -71.87% -71.51%
Operating Profit -$13.70K $12.67K
YoY Change -95.92% -116.95%
Interest Expense $39.91K $125.9K
YoY Change -24.74% 230.98%
% of Operating Profit 993.37%
Other Income/Expense, Net $1.064M -$1.658M
YoY Change 5912.31% -4258.56%
Pretax Income $1.051M -$1.650M
YoY Change -429.96% 4627.79%
Income Tax
% Of Pretax Income
Net Earnings $1.051M -$1.645M
YoY Change -429.96% 4614.05%
Net Earnings / Revenue 550.81% -408.67%
Basic Earnings Per Share $0.01 -$0.02
Diluted Earnings Per Share $0.00 -$0.02
COMMON SHARES
Basic Shares Outstanding 81.09M shares 81.09M shares
Diluted Shares Outstanding 214.9M shares 81.09M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $145.5K $100.0K
YoY Change -51.29% -73.24%
Cash & Equivalents $145.5K $98.11K
Short-Term Investments
Other Short-Term Assets $83.81K $40.00K
YoY Change -11.2% -40.51%
Inventory $216.0K $222.0K
Prepaid Expenses $83.81K $37.19K
Receivables $25.61K $4.521K
Other Receivables $0.00 $0.00
Total Short-Term Assets $470.9K $361.8K
YoY Change -68.09% -81.24%
LONG-TERM ASSETS
Property, Plant & Equipment $229.00 $325.00
YoY Change -62.64% -57.01%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $52.94K $61.57K
YoY Change -38.59% -34.56%
TOTAL ASSETS
Total Short-Term Assets $470.9K $361.8K
Total Long-Term Assets $52.94K $61.57K
Total Assets $523.9K $423.4K
YoY Change -66.46% -79.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $275.5K $290.0K
YoY Change -63.93% -66.3%
Accrued Expenses $2.103M $2.060M
YoY Change -15.87% -18.65%
Deferred Revenue
YoY Change
Short-Term Debt $50.00K $50.00K
YoY Change
Long-Term Debt Due $1.070M $1.070M
YoY Change 92.13% 81.72%
Total Short-Term Liabilities $5.814M $6.733M
YoY Change 27.54% 42.43%
LONG-TERM LIABILITIES
Long-Term Debt $138.9K $140.0K
YoY Change -77.61% -75.57%
Other Long-Term Liabilities $17.23K $30.00K
YoY Change -68.74% -52.97%
Total Long-Term Liabilities $156.1K $170.0K
YoY Change -76.88% -73.31%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.814M $6.733M
Total Long-Term Liabilities $156.1K $170.0K
Total Liabilities $5.970M $6.900M
YoY Change 14.07% 28.63%
SHAREHOLDERS EQUITY
Retained Earnings -$13.19M -$14.24M
YoY Change 15.16% 27.89%
Common Stock $81.09K $81.09K
YoY Change 0.0% 0.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.728M -$6.755M
YoY Change
Total Liabilities & Shareholders Equity $523.9K $423.4K
YoY Change -66.46% -79.07%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $1.051M -$1.645M
YoY Change -429.96% 4614.05%
Depreciation, Depletion And Amortization $290.00 $0.00
YoY Change 107.14% -100.0%
Cash From Operating Activities $53.36K -$90.00K
YoY Change -164.42% -73.09%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -740.0 -10.00K
YoY Change -109.31% -89.88%
NET CHANGE
Cash From Operating Activities 53.36K -90.00K
Cash From Investing Activities 0.000
Cash From Financing Activities -740.0 -10.00K
Net Change In Cash 52.62K -100.0K
YoY Change -170.27% -76.92%
FREE CASH FLOW
Cash From Operating Activities $53.36K -$90.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
jksm Aggregate Exercise Price Forfeited And Cancelled
AggregateExercisePriceForfeitedAndCancelled
-493500 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
81088719 shares
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements is in conformity with U.S. GAAP and requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Such estimates and assumptions impact both assets and liabilities, including but not limited to net realizable value of accounts receivable and inventory, estimated useful lives and potential impairment of property and equipment, estimate of fair value of share-based payments and derivative liabilities, estimates of fair value of warrants issued and recorded as debt discount and estimates of the probability and potential magnitude of contingent liabilities. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future nonconforming events. Accordingly, actual results could differ significantly from estimates.</p>
dei Entity Central Index Key
EntityCentralIndexKey
0000860543
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
81088719 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
81088719 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
81088719 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
033-33263
dei Entity Registrant Name
EntityRegistrantName
Jacksam Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-3566284
dei Entity Address Address Line1
EntityAddressAddressLine1
3100 Airway Avenue Suite 138
dei Entity Address City Or Town
EntityAddressCityOrTown
Costa Mesa
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92626
dei City Area Code
CityAreaCode
800
dei Local Phone Number
LocalPhoneNumber
605-3580
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
JKSM
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
81088719 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
98114 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
482908 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4521 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
222000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
214143 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
37191 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
41751 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
361826 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
738802 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
325 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
517 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
61246 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
77677 usd
CY2023Q2 us-gaap Assets
Assets
423397 usd
CY2022Q4 us-gaap Assets
Assets
816996 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
669882 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
558879 usd
CY2023Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
119672 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
80000 usd
CY2023Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
740591 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1127634 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
444444 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
444444 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
629027 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
158672 usd
CY2023Q2 us-gaap Line Of Credit
LineOfCredit
50000 usd
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
36561 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
34007 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1900759 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
491913 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1642269 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1642269 usd
CY2023Q2 jksm Subscription Payable Current
SubscriptionPayableCurrent
499999 usd
CY2022Q4 jksm Subscription Payable Current
SubscriptionPayableCurrent
499999 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6733204 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5037817 usd
CY2023Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
139709 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
580105 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
27231 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
46233 usd
CY2023Q2 us-gaap Liabilities
Liabilities
6900144 usd
CY2022Q4 us-gaap Liabilities
Liabilities
5664155 usd
CY2023Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
278270 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
272022 usd
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
81088 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
81088 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7405997 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7451916 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14242202 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12652285 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-6755017 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-5119181 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
423397 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
816996 usd
CY2023Q2 us-gaap Revenues
Revenues
402610 usd
CY2022Q2 us-gaap Revenues
Revenues
1467309 usd
us-gaap Revenues
Revenues
1031035 usd
us-gaap Revenues
Revenues
3244384 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
247589 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1042379 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
652901 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2400817 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
155021 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
424930 usd
us-gaap Gross Profit
GrossProfit
378134 usd
us-gaap Gross Profit
GrossProfit
843567 usd
CY2023Q2 us-gaap Salaries And Wages
SalariesAndWages
51274 usd
CY2022Q2 us-gaap Salaries And Wages
SalariesAndWages
273836 usd
us-gaap Salaries And Wages
SalariesAndWages
164161 usd
us-gaap Salaries And Wages
SalariesAndWages
541480 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
91076 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
225867 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
221812 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
375480 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
142350 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
499703 usd
us-gaap Operating Expenses
OperatingExpenses
385973 usd
us-gaap Operating Expenses
OperatingExpenses
916960 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
12671 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-74773 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-7839 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-73393 usd
CY2023Q2 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-1532147 usd
CY2022Q2 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
77899 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-1408846 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
364997 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
125870 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
38029 usd
us-gaap Interest Expense
InterestExpense
173232 usd
us-gaap Interest Expense
InterestExpense
297123 usd
CY2023Q2 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 usd
CY2022Q2 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 usd
CY2023Q2 jksm Gain On Settlement Of Notes Payable
GainOnSettlementOfNotesPayable
0 usd
CY2022Q2 jksm Gain On Settlement Of Notes Payable
GainOnSettlementOfNotesPayable
0 usd
jksm Gain On Settlement Of Notes Payable
GainOnSettlementOfNotesPayable
0 usd
jksm Gain On Settlement Of Notes Payable
GainOnSettlementOfNotesPayable
0 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1658017 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
39870 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1582078 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
67874 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1645346 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-34903 usd
us-gaap Net Income Loss
NetIncomeLoss
-1589917 usd
us-gaap Net Income Loss
NetIncomeLoss
-5519 usd
CY2023Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
23086 usd
CY2022Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
23087 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
45919 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
45920 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1668432 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-57990 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1635836 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-51439 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
81088719 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
80132342 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
81088719 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
77605012 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81088719 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
80132342 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81088719 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
77605012 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4514303 usd
CY2022Q1 jksm Issuance Of Series B Preferred Stock Net Of Fees Amount
IssuanceOfSeriesBPreferredStockNetOfFeesAmount
890000 usd
CY2022Q1 jksm Common Stock And Warrants Issued In Connection With Preferred Stock Amount
CommonStockAndWarrantsIssuedInConnectionWithPreferredStockAmount
0 usd
CY2022Q1 jksm Dividends On Series A And B Preferred Stock
DividendsOnSeriesAAndBPreferredStock
-22833 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
29384 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-3617752 usd
CY2022Q2 jksm Common Stock Issued For Share Payable Amount
CommonStockIssuedForSharePayableAmount
0 usd
CY2022Q2 jksm Common Stock Issued For Services Amount
CommonStockIssuedForServicesAmount
68977 usd
CY2022Q2 jksm Common Stock And Warrants Issued In Connection With Preferred Stock Amount
CommonStockAndWarrantsIssuedInConnectionWithPreferredStockAmount
0 usd
CY2022Q2 jksm Dividends On Series A And B Preferred Stock
DividendsOnSeriesAAndBPreferredStock
-23087 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-34903 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-3606765 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-5119181 usd
CY2023Q1 jksm Dividends On Series A And B Preferred Stock
DividendsOnSeriesAAndBPreferredStock
-22833 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
55429 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-5086585 usd
CY2023Q2 jksm Dividends On Series A And B Preferred Stock
DividendsOnSeriesAAndBPreferredStock
-23086 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1645346 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-6755017 usd
us-gaap Net Income Loss
NetIncomeLoss
-1589917 usd
us-gaap Net Income Loss
NetIncomeLoss
-5519 usd
us-gaap Depreciation
Depreciation
192 usd
us-gaap Depreciation
Depreciation
716 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
68977 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
96095 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
56765 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
16431 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
12493 usd
us-gaap Interest Expense Other
InterestExpenseOther
0 usd
us-gaap Interest Expense Other
InterestExpenseOther
141020 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-1408846 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
364997 usd
us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 usd
us-gaap Impairment Of Investments
ImpairmentOfInvestments
18800 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4521 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
671521 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7857 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
47539 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-4560 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
58643 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-16448 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-10437 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
111004 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
454962 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-387043 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-67468 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-368658 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-472391 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
50000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
0 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-300000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
163988 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
65136 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
252751 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
890000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-16136 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
501237 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-384794 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
28846 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
482908 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
344811 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
98114 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
373657 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
5946 usd
us-gaap Interest Paid Net
InterestPaidNet
3049 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
105822 usd
jksm Common Stock Issued For Deferred Finance Costs
CommonStockIssuedForDeferredFinanceCosts
0 usd
jksm Common Stock Issued For Deferred Finance Costs
CommonStockIssuedForDeferredFinanceCosts
2670 usd
jksm Common Stock Issued To Settle Share Payable
CommonStockIssuedToSettleSharePayable
0 usd
jksm Common Stock Issued To Settle Share Payable
CommonStockIssuedToSettleSharePayable
331600 usd
jksm Preferred Stock Dividends Non Cash
PreferredStockDividendsNonCash
45919 usd
jksm Preferred Stock Dividends Non Cash
PreferredStockDividendsNonCash
45920 usd
CY2023Q2 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
250000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
264659 usd
CY2023Q2 jksm Inventory Allowance
InventoryAllowance
18800 usd
CY2023Q2 us-gaap Deferred Revenue
DeferredRevenue
740591 usd
CY2023Q2 jksm Machine Sales
MachineSales
105000 usd
CY2022Q2 jksm Machine Sales
MachineSales
1157961 usd
jksm Machine Sales
MachineSales
448000 usd
jksm Machine Sales
MachineSales
2191084 usd
CY2023Q2 jksm Non Machine Sales
NonMachineSales
297610 usd
CY2022Q2 jksm Non Machine Sales
NonMachineSales
309348 usd
jksm Non Machine Sales
NonMachineSales
583035 usd
jksm Non Machine Sales
NonMachineSales
1053300 usd
CY2023Q2 us-gaap Revenues
Revenues
402610 usd
CY2022Q2 us-gaap Revenues
Revenues
1467309 usd
us-gaap Revenues
Revenues
1031035 usd
us-gaap Revenues
Revenues
3244384 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-1668432 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-57990 usd
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-1635836 usd
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-51439 usd
CY2023Q2 jksm Dividends Preferred Stock1
DividendsPreferredStock1
0 usd
CY2022Q2 jksm Dividends Preferred Stock1
DividendsPreferredStock1
0 usd
jksm Dividends Preferred Stock1
DividendsPreferredStock1
0 usd
jksm Dividends Preferred Stock1
DividendsPreferredStock1
0 usd
CY2023Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 usd
CY2022Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 usd
CY2023Q2 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0 usd
CY2022Q2 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0 usd
us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0 usd
us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0 usd
CY2023Q2 jksm Net Income Loss For Dilutive Calculation
NetIncomeLossForDilutiveCalculation
-1668432 usd
CY2022Q2 jksm Net Income Loss For Dilutive Calculation
NetIncomeLossForDilutiveCalculation
-57990 usd
jksm Net Income Loss For Dilutive Calculation
NetIncomeLossForDilutiveCalculation
-1635836 usd
jksm Net Income Loss For Dilutive Calculation
NetIncomeLossForDilutiveCalculation
-51439 usd
CY2023Q2 jksm Weighted Average Shares Outstanding
WeightedAverageSharesOutstanding
81088719 usd
CY2022Q2 jksm Weighted Average Shares Outstanding
WeightedAverageSharesOutstanding
80132342 usd
jksm Weighted Average Shares Outstanding
WeightedAverageSharesOutstanding
81088719 usd
jksm Weighted Average Shares Outstanding
WeightedAverageSharesOutstanding
77605012 usd
CY2023Q2 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 usd
CY2022Q2 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 usd
CY2023Q2 jksm Dilutive Effect Of Convertible Debt
DilutiveEffectOfConvertibleDebt
0 usd
CY2022Q2 jksm Dilutive Effect Of Convertible Debt
DilutiveEffectOfConvertibleDebt
0 usd
jksm Dilutive Effect Of Convertible Debt
DilutiveEffectOfConvertibleDebt
0 usd
jksm Dilutive Effect Of Convertible Debt
DilutiveEffectOfConvertibleDebt
0 usd
CY2023Q2 jksm Dilutive Effect Of Common Stock Warrants
DilutiveEffectOfCommonStockWarrants
0 usd
CY2022Q2 jksm Dilutive Effect Of Common Stock Warrants
DilutiveEffectOfCommonStockWarrants
0 usd
jksm Dilutive Effect Of Common Stock Warrants
DilutiveEffectOfCommonStockWarrants
0 usd
jksm Dilutive Effect Of Common Stock Warrants
DilutiveEffectOfCommonStockWarrants
0 usd
CY2023Q2 jksm Weighted Average Shares Outstanding For Diluted Net Income Loss Per Share
WeightedAverageSharesOutstandingForDilutedNetIncomeLossPerShare
81088719 usd
CY2022Q2 jksm Weighted Average Shares Outstanding For Diluted Net Income Loss Per Share
WeightedAverageSharesOutstandingForDilutedNetIncomeLossPerShare
80132342 usd
jksm Weighted Average Shares Outstanding For Diluted Net Income Loss Per Share
WeightedAverageSharesOutstandingForDilutedNetIncomeLossPerShare
81088719 usd
jksm Weighted Average Shares Outstanding For Diluted Net Income Loss Per Share
WeightedAverageSharesOutstandingForDilutedNetIncomeLossPerShare
77605012 usd
CY2023Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
15189056 shares
CY2023Q2 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
132275132 shares
CY2023Q2 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
18066667 shares
CY2022Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
15189056 shares
CY2022Q2 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
2469136 shares
CY2022Q2 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
18066667 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
2777778 shares
CY2022Q2 jksm Share Payable Equity Issued
SharePayableEquityIssued
2222223 shares
CY2023Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
0 usd
CY2022Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
19000 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
220 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
25500 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20644 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20644 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20319 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20127 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
325 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
517 usd
us-gaap Depreciation
Depreciation
192 usd
us-gaap Depreciation
Depreciation
716 usd
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
669882 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
558879 usd
CY2023Q2 us-gaap Notes Payable
NotesPayable
768736 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
832872 usd
CY2023Q2 jksm Debt Instrument Unamortized Discount1
DebtInstrumentUnamortizedDiscount1
0 usd
CY2022Q4 jksm Debt Instrument Unamortized Discount1
DebtInstrumentUnamortizedDiscount1
-94095 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
629027 usd
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.10 pure
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
158672 usd
CY2023Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
139709 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
580105 usd
CY2023Q2 jksm Principal Amount
PrincipalAmount
50000 usd
us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2023-06-30
us-gaap Deferred Purchased Power Costs
DeferredPurchasedPowerCosts
1000 usd
jksm Amortization Of Debt Discount
AmortizationOfDebtDiscount
95095 usd
jksm Amortization Of Debt Discount
AmortizationOfDebtDiscount
49980 usd
CY2023Q2 us-gaap Accounts Payable Interest Bearing Noncurrent
AccountsPayableInterestBearingNoncurrent
240122 usd
CY2022Q4 us-gaap Accounts Payable Interest Bearing Noncurrent
AccountsPayableInterestBearingNoncurrent
169855 usd
CY2023Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
444444 usd
CY2022Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
444444 usd
CY2023Q2 jksm Debt Discount And Deferred Finance Costs On Short Term Convertible Notes
DebtDiscountAndDeferredFinanceCostsOnShortTermConvertibleNotes
0 usd
CY2022Q4 jksm Debt Discount And Deferred Finance Costs On Short Term Convertible Notes
DebtDiscountAndDeferredFinanceCostsOnShortTermConvertibleNotes
0 usd
CY2023Q2 jksm Current Convertible Notes Payable Net Of Discount
CurrentConvertibleNotesPayableNetOfDiscount
444444 usd
CY2022Q4 jksm Current Convertible Notes Payable Net Of Discount
CurrentConvertibleNotesPayableNetOfDiscount
444444 usd
CY2023Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2022Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
jksm Convertible Notes Payable1
ConvertibleNotesPayable1
444444 usd
jksm Gain Loss On Changes In Fair Value Derivatives
GainLossOnChangesInFairValueDerivatives
-1408846 usd
jksm Gain Loss On Changes In Fair Value Derivatives
GainLossOnChangesInFairValueDerivatives
364977 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 jksm Common Stock Designated
CommonStockDesignated
200000000 shares
CY2023Q2 jksm Preferred Stock Designated
PreferredStockDesignated
30000000 shares
CY2023Q2 jksm Shares Balance Of Subscriptions Payable Liability
SharesBalanceOfSubscriptionsPayableLiability
2777778 shares
CY2022Q4 jksm Subscriptions Payable Liability Balance
SubscriptionsPayableLiabilityBalance
499999 usd
us-gaap Dividends
Dividends
6248 usd
CY2023Q2 jksm Accrued Dividend
AccruedDividend
26270 usd
CY2022Q4 jksm Accrued Dividend
AccruedDividend
20022 usd
jksm Redemption Value
RedemptionValue
278270 usd
CY2022 jksm Redemption Value
RedemptionValue
272022 usd
jksm Shares Remaining To Be Issued
SharesRemainingToBeIssued
2000000 shares
jksm Fair Value Of Common Stock
FairValueOfCommonStock
139800 usd
jksm Aggregate Number Of Stock Warrant Beginning Balance
AggregateNumberOfStockWarrantBeginningBalance
14279965 shares
jksm Aggregate Stock Warrant Exercise Price Beginning Balance
AggregateStockWarrantExercisePriceBeginningBalance
2946044 usd
jksm Weighted Average Stock Warrant Exercise Price Beginning Balance
WeightedAverageStockWarrantExercisePriceBeginningBalance
0.21
jksm Aggregate Exercise Price Granted
AggregateExercisePriceGranted
0 usd
jksm Aggregate Exercise Price Exercised1
AggregateExercisePriceExercised1
0 usd
jksm Aggregate Exercise Price Exercised
AggregateExercisePriceExercised
0 usd
jksm Less Forfeited And Cancelled
LessForfeitedAndCancelled
-1701389 usd
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.29
jksm Aggregate Number Of Stock Warrant Ending Balance
AggregateNumberOfStockWarrantEndingBalance
12578576 shares
jksm Aggregate Stock Warrant Exercise Price Ending Balance
AggregateStockWarrantExercisePriceEndingBalance
2452544 usd
jksm Weighted Average Stock Warrant Exercise Price Ending Balance
WeightedAverageStockWarrantExercisePriceEndingBalance
0.19
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P1Y9M
jksm Lease Agreement Period
LeaseAgreementPeriod
beginning February 15, 2022 through February 28, 2025
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
3267 usd
jksm Lease Payments Increased Percentage
LeasePaymentsIncreasedPercentage
0.04 pure
CY2023Q2 jksm Right Of Use Asset And Lease Liability
RightOfUseAssetAndLeaseLiability
105822 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
20108 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
16757 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
3892 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
34274 usd
us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
us-gaap Sublease Income
SubleaseIncome
0 usd
us-gaap Sublease Income
SubleaseIncome
0 usd
us-gaap Lease Cost
LeaseCost
24000 usd
us-gaap Lease Cost
LeaseCost
51031 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
61246 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
77677 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
36561 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
34007 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
27231 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
46233 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
63792 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
80240 usd
CY2023Q2 jksm Incremental Borrowing Rate Percentage
IncrementalBorrowingRatePercentage
0.10 pure
jksm Lease Remaining Terms
LeaseRemainingTerms
P1Y8M1D
us-gaap Long Term Debt Weighted Average Interest Rate Over Time
LongTermDebtWeightedAverageInterestRateOverTime
0.10 pure
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
20386 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
42123 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
7065 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
0 usd
CY2023Q2 jksm Lessee Operating Lease Liability Payments Due After Year Three
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearThree
0 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
69574 usd
CY2023Q2 jksm Interest Lessee Operating Lease Liability
InterestLesseeOperatingLeaseLiability
5782 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
63792 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1642269 usd

Files In Submission

Name View Source Status
jksm-20230630_cal.xml Edgar Link unprocessable
jksm-20230630_pre.xml Edgar Link unprocessable
0001477932-23-007182-index-headers.html Edgar Link pending
0001477932-23-007182-index.html Edgar Link pending
0001477932-23-007182.txt Edgar Link pending
0001477932-23-007182-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
jksm-20230630.xsd Edgar Link pending
jksm_10q.htm Edgar Link pending
jksm_ex311.htm Edgar Link pending
jksm_ex321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
jksm-20230630_def.xml Edgar Link unprocessable
jksm-20230630_lab.xml Edgar Link unprocessable
jksm_10q_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending